首页> 外文学位 >Investigation of resveratrol metabolism using liquid chromatography-mass spectrometry.
【24h】

Investigation of resveratrol metabolism using liquid chromatography-mass spectrometry.

机译:使用液相色谱-质谱法研究白藜芦醇代谢。

获取原文
获取原文并翻译 | 示例

摘要

This thesis describes the drug development investigations of in vitro and in vivo metabolism of resveratrol as a dietary cancer chemopreventive agent using liquid chromatography-mass spectrometry.; In the present study, human liver-derived in vitro experimental systems have been used extensively for the evaluation of drug metabolism. Cryopreserved human and rat hepatocytes were compared to human liver microsomes in the evaluation of resveratrol metabolism. Differentiated Caco-2 cell monolayers were used in the investigatation of the intestinal metabolism of resveratrol. In vivo studies using urine, serum, plasma, and tissues provided an overall indication of drug metabolism resulting from multiple organ systems. All of the metabolism profiles including metabolite structures were obtained using HPLC with photodiode array (DAD) UV detection, connected on-line with electrospray mass spectrometry (LC-DAD-MS) or electrospray tandem mass spectrometry (LC-UV-MS-MS). Research results from the human, rat, and mouse experiments indicate that traps-resveratrol-3-O-glucuronide is the primary metabolite of resveratrol in human liver and rat urine, and that traps-resveratrol-3-O-glucuronide and traps-resveratrol-3-sulfate are both significant metabolites in human serum, rat plasma and lung tissue, mouse serum, and formed by rat hepatocytes and human Caco-2 cells. It is important to note that no Phase I metabolites of resveratrol such as oxidations, reductions or hydrolyses were detected in any of these systems.; Recombinant human enzymes including specific cytochrome P450, UDP-glucuronosyltransferases (UGT), and sulfotransferases (SULT) were used for phenotyping and inhibition studies. UGT1A1, UGT1A9 and SULT1A3, SULT1E were the major UGT and SULT isoforms responsible for human resveratrol metabolism. Using a new LC-MS-MS method for the evaluation of inhibition of multiple CYP isozyme, traps-resveratrol was identified as a marginal inhibitor of CYP3A4, a weak inhibitor of CYP2C19. traps-Resveratrol-3-sulfate did not inhibit any of the five CYP isozymes investigated.; An LC-DAD-MS and LC-UV-MS-MS method for quantitative analysis of cis- and traps-resveratrol was developed and applied to the analysis of blueberry and bilberry samples. traps-Resveratrol was detected in High Bush Michigan blueberries, northern North American wild blueberries and European bilberries, which shows that blueberry and bilberry may serve as alternative dietary sources for the antioxidant resveratrol. No cis-resveratrol was detected. (Abstract shortened by UMI.)
机译:本文采用液相色谱-质谱联用技术研究了白藜芦醇作为饮食癌症化学预防剂的体外体内代谢的药物开发研究。在本研究中,人类肝脏来源的体外实验系统已被广泛用于评估药物代谢。将冷冻保存的人和大鼠肝细胞与人肝微粒体进行比较,以评估白藜芦醇的代谢。分化的Caco-2细胞单层被用于白藜芦醇的肠道代谢研究。使用尿液,血清,血浆和组织的体内研究提供了由多个器官系统引起的药物代谢的总体指标。使用具有光电二极管阵列(DAD)UV检测的HPLC,与电喷雾质谱(LC-DAD-MS)或电喷雾串联质谱(LC-UV-MS-MS)在线连接获得的所有代谢谱(包括代谢物结构) 。人类,大鼠和小鼠实验的研究结果表明, traps -白藜芦醇-3- O -葡糖苷酸是人肝脏和大鼠尿液中白藜芦醇的主要代谢产物,并且 traps -白藜芦醇-3- O -葡萄糖醛酸和-白藜芦醇-3-硫酸盐都是人血清,大鼠血浆和血浆中的重要代谢物。肺组织,小鼠血清,并由大鼠肝细胞和人Caco-2细胞形成。重要的是要注意,在任何这些系统中都没有检测到白藜芦醇的I期代谢产物,例如氧化,还原或水解。重组人类酶包括特定的细胞色素P450,UDP-葡萄糖醛酸转移酶(UGT)和磺基转移酶(SULT)用于表型和抑制研究。 UGT1A1,UGT1A9和SULT1A3,SULT1E是负责人白藜芦醇代谢的主要UGT和SULT亚型。使用一种新的LC-MS-MS方法评估多种CYP同工酶的抑制作用,将 traps -白藜芦醇鉴定为CYP3A4的边际抑制剂,CYP3A4是一种弱CYP2C19抑制剂。 traps -白藜芦醇-3-硫酸盐没有抑制所研究的五个CYP同工酶中的任何一个。建立了LC-DAD-MS和LC-UV-MS-MS定量分析顺式-和 traps -白藜芦醇的方法,并将其用于蓝莓和越桔的分析。样品。在密歇根州高布什蓝莓,北美北部野生蓝莓和欧洲越橘中检测到 traps -白藜芦醇,这表明蓝莓和越橘可以作为抗氧化剂白藜芦醇的替代饮食来源。没有检测到 cis -白藜芦醇。 (摘要由UMI缩短。)

著录项

  • 作者

    Yu, Chongwoo.;

  • 作者单位

    University of Illinois at Chicago.;

  • 授予单位 University of Illinois at Chicago.;
  • 学科 Chemistry Analytical.; Chemistry Pharmaceutical.; Health Sciences Pharmacology.
  • 学位 Ph.D.
  • 年度 2002
  • 页码 131 p.
  • 总页数 131
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 化学;药物化学;药理学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号